# Peripheral KV7 Activation for Pain Relief

> **NCT06971250** · EARLY_PHASE1 · COMPLETED · sponsor: **Stefan Heber** · enrollment: 32 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Capsaicin only (7.6 ng)
- **DRUG:** Capsaicin + Flupirtine 0.5 µg
- **DRUG:** Capsaicin + Flupirtine 1.2 µg
- **DRUG:** Capsaicin + Flupirtine 3.0 µg
- **DRUG:** Capsaicin + Flupirtine 7.6 µg
- **DRUG:** Placebo (SIF only, no capsaicin or Flupirtine)
- **DRUG:** Room Temperature Injection (Control)
- **DRUG:** Heated injection without Flupirtine
- **DRUG:** Heated Injection with Flupirtine 124 µg

## Key facts

- **NCT ID:** NCT06971250
- **Lead sponsor:** Stefan Heber
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-08
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-05-28
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06971250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06971250, "Peripheral KV7 Activation for Pain Relief". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06971250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*